
51 - 200 employees
🧬 Biotechnology
🤖 Artificial Intelligence
⚕️ Healthcare Insurance
💰 $25M Series A on 2023-03
Biotechnology • Artificial Intelligence • Healthcare Insurance
Outpace Bio is a biotechnology company revolutionizing cell therapy through advanced protein design. The company is focused on curing solid tumors by programming cells to make better decisions inside the body, enhancing immune responses and maximizing the potency, specificity, and safety of cell therapies. Outpace Bio uses AI-powered protein design to create new proteins and guide engineered cells in recognizing and eliminating cancer. Its platform technologies, such as OUTSMART™, OUTLAST™, and CO-LOCKR™, aim to solve the complex mechanisms that hinder effective cancer treatment. The company aspires to create curative cell therapy products that can address a wide range of cancer indications, leveraging a deep understanding of biology and technology.
🕒 May 8
Senior Manager/Associate Director overseeing the operational aspects of cell-therapy clinical trials at Outpace Bio. Ensuring quality and compliance from setup to final report.
☕ Washington – Remote
💵 $160k - $217k / year
💰 $25M Series A on 2023-03
⏰ Full Time
🟠 Senior
🏥 Clinical Operations
🦅 H1B Visa Sponsor
🕒 April 28
Clinical Scientist leading clinical development of programmed T cell therapies at Outpace Bio. Collaborating with cross-functional teams to design and advance oncology cell therapies into the clinic.
☕ Washington – Remote
💵 $226k - $267k / year
💰 $25M Series A on 2023-03
⏰ Full Time
🟡 Mid-level
🟠 Senior
🧪 Clinical Research
🦅 H1B Visa Sponsor